Lv4
416 积分 2022-04-13 加入
The minimally important difference in the six-minute walk test predicts clinical worsening in pulmonary arterial hypertension
4个月前
已完结
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
4个月前
已完结
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): 1-Year Results from the CHEST-2 Long-term Extension Study
4个月前
已关闭
Riociguat for the Treatment of Pulmonary Arterial Hypertension
4个月前
已完结
A new perspective on targeting pulmonary arterial hypertension: Programmed cell death pathways (Autophagy, Pyroptosis, Ferroptosis)
4个月前
已完结
Diagnosis and Treatment of Pulmonary Arterial Hypertension
4个月前
已完结
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
4个月前
已完结
抗特发性肺纤维化药物吡非尼酮和舒非尼酮在小鼠结核病模型肺损伤中的保护作用研究
5个月前
已完结
Model‐informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis
5个月前
已完结
Taiwanese Dermatological Association consensus for the diagnosis and management of prurigo nodularis
6个月前
已完结
皖公网安备34019202002308
